212 related articles for article (PubMed ID: 27769766)
41. Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Karabulut A; Demirlenk S; Sevket O
Gynecol Endocrinol; 2012 Apr; 28(4):245-8. PubMed ID: 21961995
[TBL] [Abstract][Full Text] [Related]
42. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
Rubina VV; Korchevaia TA; Kravchenko LIa
Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
[No Abstract] [Full Text] [Related]
43. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
Mehrl J
Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
[No Abstract] [Full Text] [Related]
44. The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne.
Dieben TO; Vromans L; Theeuwes A; Bennink HJ
Contraception; 1994 Oct; 50(4):373-82. PubMed ID: 7813225
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
Plewig G; Cunliffe WJ; Binder N; Höschen K
Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
[TBL] [Abstract][Full Text] [Related]
46. Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.
Villaseca P; Hormaza P; Cárdenas I; Oestreicher E; Arteaga E
Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):155-65. PubMed ID: 15697105
[TBL] [Abstract][Full Text] [Related]
47. Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Mueck AO;
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):170-171. PubMed ID: 28540758
[No Abstract] [Full Text] [Related]
48. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
Döring HF; Ilgner M
Z Hautkr; 1983 May; 58(10):761-7. PubMed ID: 6224353
[TBL] [Abstract][Full Text] [Related]
49. Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study.
Carlborg L
Acta Obstet Gynecol Scand Suppl; 1986; 134():29-32. PubMed ID: 2949481
[TBL] [Abstract][Full Text] [Related]
50. [Oral contraceptives, risks and hazards].
Revuz J
Ann Dermatol Venereol; 2014 Jan; 141(1):5-6. PubMed ID: 24461087
[No Abstract] [Full Text] [Related]
51. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
52. Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Karakurt F; Carlioglu A; Kaygusuz I; Gumus II; Uz B; Akdeniz D
Arch Gynecol Obstet; 2014 Jan; 289(1):135-40. PubMed ID: 23880889
[TBL] [Abstract][Full Text] [Related]
53. Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism.
Batukan C; Muderris II; Ozcelik B; Ozturk A
Gynecol Endocrinol; 2007 Jan; 23(1):38-44. PubMed ID: 17484511
[TBL] [Abstract][Full Text] [Related]
54. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
[TBL] [Abstract][Full Text] [Related]
55. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
Barth JH; Cherry CA; Wojnarowska F; Dawber RP
Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
[TBL] [Abstract][Full Text] [Related]
56. [Anti-androgenic steroid cyproterone acetate. Clinical pharmacology and therapeutic use in hirsutism and acne].
van Wayjen RG; van den Ende A
Ned Tijdschr Geneeskd; 1976 Jan; 120(5):189-95. PubMed ID: 129710
[No Abstract] [Full Text] [Related]
57. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
[TBL] [Abstract][Full Text] [Related]
58. Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.
Vrbikova J; Dvorakova K; Hill M; Starka L
Endocr Regul; 2006 Dec; 40(4):119-23. PubMed ID: 17201585
[TBL] [Abstract][Full Text] [Related]
59. Ethinylestradiol + cyproterone: back in France for acne and hirsutism, despite frequent off-label prescription.
Prescrire Int; 2014 Jul; 23(151):183. PubMed ID: 25162092
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic alternatives for the hirsute woman.
Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
